Mapping of conformational mAb epitopes to the C domain of human angiotensin l-converting enzyme

Journal of Proteome Research

Volumn 7, Issue 8, 2008, Pages 3396-3411

  Naperova, Irina A ^a   Balyasnikova, Irina V ^b   Schwartz, David E ^b   Watermeyer, Jean ^c   Sturrock, Edward D ^c   Kost, Olga A ^a   Danilov, Sergei M ^b  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Angiotensin converting enzyme; CD143; Conformation; Monoclonal antibodies 'testicular ace

Indexed keywords

ASPARAGINE; DIPEPTIDYL CARBOXYPEPTIDASE; GLYCAN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 1B3; MONOCLONAL ANTIBODY 1B8; MONOCLONAL ANTIBODY 1E10; MONOCLONAL ANTIBODY 2B11; MONOCLONAL ANTIBODY 2H9; MONOCLONAL ANTIBODY 3F10; MONOCLONAL ANTIBODY 3F11; MONOCLONAL ANTIBODY 4E3; UNCLASSIFIED DRUG; EPITOPE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ANTIGEN BINDING; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHO CELL; CONTROLLED STUDY; CROSS REACTION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; FLOW CYTOMETRY; GLYCOSYLATION; GOAT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCONTRACEPTION; KIDNEY HOMOGENATE; LUNG HOMOGENATE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; RHESUS MONKEY; SEMINAL PLASMA; SITE DIRECTED MUTAGENESIS; SOMATIC CELL; SPECIES DIFFERENCE; SPERMATOZOON; AMINO ACID SEQUENCE; ANIMAL; CHEMICAL STRUCTURE; CRICETULUS; HAMSTER; IMMUNOLOGY; MACACA; METABOLISM; MOLECULAR GENETICS; PROTEIN TERTIARY STRUCTURE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; CHO CELLS; CRICETINAE; CRICETULUS; EPITOPE MAPPING; EPITOPES; GLYCOSYLATION; HUMANS; MACACA; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDYL-DIPEPTIDASE A; PROTEIN STRUCTURE, TERTIARY; SPECIES SPECIFICITY;

EID: 53049083477     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr800142w     Document Type: Article

References (81)

1. Riordan, J. F.; Ehlers, M. R. W. Angiotensin-converting enzyme: new concepts concerning its biological role. Biochemistry 1989, 28, 5311-5318.
2. Danilov, S. M.; Franke, F. E.; Erdos, E. G. Angiotensin-converting enzyme (CD 143) In: Leucocyte Typing VI: White Cell differentiation Antigens.; Kishimoto, T., et al., Eds.; Garland Publishing Inc.: New York, 1997.; pp 746-749.
3. Franke, F. E.; Metzger, R.; E-ohle, R.-M.; Kerkman, L.; Alhenc-Gelas, F.; Danilov, S. M. Angiotensin I-converting enzyme (CD 143) on endothelial cells in normal and in pathological conditions. In: Leucocyte Typing VI: White Cell Differentiation Antigens.; Kishimoto, T., et al., Eds.; Garland Publishing Inc.: New York, 1997.; pp 749-751.
4. Corvol, P.; Eyries, M.; Soubrier, F. Peptidyl-dipeptidase A/Angiotensin I-converting enzyme. In: Handbook of Proteolytic Enzymes.; Barret, A. A., Rawlings, N. D., Woessner, J. F., Eds.; Elsevier Academic Press: New York, 2004.; pp 332-349.
5. Bernstein, K. E.; Xiao, H. D.; Frenzel, K.; Li, P.; Shen, X. Z.; Adams, J. W.; Fuchs, S. Six truisms concerning ACE and the renin-angiotensin system educed from the genetic analysis of mice. Circ. Res. 2005, 96, 1135-1144.
6. Danilov, S. M.; Sadovnikova, E.; Scharenborg, N.; Balyasnikova, I. V.; Svinareva, D. A.; Semikina, E. L.; Parovichnikova, E. N.; Savchenko, V. G.; Adema, G. J. Angiotensin-converting enzyme (CD 143) is abundandy expressed by dendritic cells and discriminates human monocyte-derived dendritic cells from acute myeloid leukemia-derived dendritic cells. Exp. Hem. 2003, 31, 1301-1309.
7. Soubrier, F.; Alhenc-Gelas, F.; Hubert, C.; Allegrini, I.; John, M.; Tregear, G.; Corvol, P. Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc. Natl. Acad. Sci. U.SA. 1988, 85, 9386-9390.
8. Ehlers, M. R.; Fox, E. A.; Strydom, D. J.; Riordan, J. F. Molecular cloning of human testicular angiotensin-converting enzyme: the testis isozyme is identical to the C-terminal half of endothelial ACE. Proc. Natl. Acad. Sci. U.SA. 1989, 86, 7741-7745.
9. Lattion, A. L.; Soubrier, F.; AllegriniJ.; Hubert, C.; Corvol, P.; Alhenc-Gelas, F. The testicular transcript of the angiotensin I-converting enzyme encodes for the ancestral, non-duplicated form of the enzyme. FEBS Lett. 1989, 252, 99-104.
10. Danilov, S.; Jaspard, E.; Churakova, T.; Towbin, H.; Savoie, F.; Wei, L.; Alhenc-Gelas, F. Structure-function analysis of angiotensin I-converting enzyme using monoclonal antibodies. J Biol. Chem. 1994, 269, 26806-26814.
11. Balyasnikova, I. V.; Woodman, Z. L.; Albrecht, R. F., II.; Natesh, R.; Acharya, K. R.; Sturrock, E. D.; Danilov, S. M. Localization of an N domain region of angiotensin-converting enzyme involved in the regulation of ectodomain shedding using monoclonal antibodies. J Proteome Res. 2005, 4, 258-267.
12. Skirgello, O. E.; Balyasnikova, I. V.; Binevski, P. V.; Sun, Z.-L.; Baskin, I.I.; Palyulin, V. A.; Nesterovitch, A. B.; Albrecht, R. F., II.; Kost, O. A.; Danilov, S. M. Inhibitory antibodies to human angiotensin-converting enzyme: fine epitope mapping and mechanism of action. Biochemistry 2006, 45, 4831-4847.
13. Balyasnikova, I. V.; Skirgello, O. E.; Binevski, P. V.; Nesterovitch, A. B.; Albrecht, R. F., II.; Kost, O. A.; Danilov, S. M. Monoclonal antibodies 1G12 and 6A12 to the N domain of human angiotensin-converting enzyme:fine epitope mapping and antibody-based method for revelation and quantification of ACE inhibitors in the human blood. J Proteome Res. 2007, 6, 1580-1594.
14. Danilov, S. M.; Watermeyer, J. M.; Balyasnikova, I. V.; Gordon, K.; Kugaevskaya, E. V.; Elisseeva, Y. E.; Albrecht, R. F., II.; Sturrock, E. D. Fine epitope mapping of mAb 5F1 reveals anticatalytic activity. Biochemistry 2007, 46, 9019-9031.
15. Balyasnikova, I. V.; Metzger, R.; Franke, F. E.; Danilov, S. M. Monoclonal antibodies to denatured human ACE (CD143): broad species specificity, reactivity on paraffin-section, and detection of subtle conformational changes in the C-terminal domain of ACE. Tissue Antigens 2003, 61, 49-62.
16. Balyasnikova, I. V.; Sun, Z.-L.; Franke, F. E.; Berestetskaya, Y. V.; Chubb, A. J.; Albrecht, R. F., II.; Sturrock, E. D.; Danilov, S. M. Monoclonal antibodies 1B3 and 5C8 as probes for monitoring the nativity of C-terminal end of soluble angiotensin-converting enzyme (ACE). Hybridoma 2005, 24, 14-26.
17. Stevens, J.; Danilov, S. M.; Fanburg, B. L.; Lanzillo, L. L. A sensitive two-site sandwich immunoassay for human angiotensin-converting enzyme utilizing monoclonal antibodies. J Immunol. Methods 1990, 32, 263-273.
18. Danilov, S. M.; Savoie, F.; Lenoir, B.; Jeunemaitre, X.; Azizi, M.; Tamow, L.; Alhenc-Gelas, F. Development of enzyme-linked immunoassays for human angiotensin I-converting enzyme suitable for large-scale studies. J Hypertens. 1996, 14, 719-727.
19. Nikolaeva, M. A.; Balyasnikova, I. V.; Alexinskaya, M. A.; Metzfer, R.; Franke, F. E.; Albrecht, R. F., II.; Kulakov, V. I.; Sukhikh, G. T.; Danilov, S. M. Testicular isoform of angiotensin I-converting enzyme (ACE, CD143) on the surface of human spermatozoa: revelation and quantification using monoclonal antibodies. Am. J. Reprod. Immunol. 2006, 55, 54-68.
20. Balyasnikova, I. V.; Karran, E. H.; Albrecht, R. F. II.; Danilov, S. M. Epitope-specific cleavage of angiotensin-converting enzyme from the cell surface. Biochem. J. 2002, 362, 585-595.
21. Muzykantov, V. R.; Atochina, E. N.; Ischiropoulos, H.; Danilov, S. M.; Fisher, A. B. Immunotargeting of antioxidant enzymes to the pulmonary endothelium. Proc. Natl. Acad. Sci. USA 1996, 93, 5213-5218.
22. Atochina, E. N.; Balyasnikova, I. V.; Danilov.; S. M.; Granger, D. N.; Fisher, A. B.; Muzykantov, V. R. Catalase targeting to the surface endothelial antigens protects pulmonary vasculature against oxidative insult. Am. J. Physiol. (Lung Physiol.) 1998, 275, L806-L817.
23. Nowak, K.; Weih, S.; Metzger, R.; Albrecht, R. F. II.; Post, S.; Hohenberger.; P.; Gebhard, M. M.; Danilov, S. M. Immunotargeting of catalase to lung endothelium via anti-angiotensin-converting enzyme antibodies attenuates ischemia-reperfusion injury of the lung in vivo. Am. J. Physiol. (Lung Physiol) 2007, 293, L162-169.
24. Reynolds, P. N.; Zinn, K. R.; Gavrilyuk, V. D.; Balyasnikova, I. V.; Rogers, B. E.; Buchsbaum, D. J.; Wang, M. H.; Miletich, D. J.; Crizzle, W. E.; Douglas, J. T.; Danilov, S. M.; Curiel, D. T. A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivo. Mol. Ther. 2000, 2, 562-578.
25. Reynolds, P. N.; Nicklin, S. A.; Kaliberova, L.; Boatman, B. G.; Grizzle, W. E.; Balyasnikova, I. V.; Baker, A. H.; Danilov, S. M.; Curiel, D. T. Combined transcriptional and transductional targeting improves the specificity of transgene expression in vivo. Nat. Biotechnol. 2001, 19, 838-842.
26. Muller, W. H.; Brosnan, M. J.; Graham, D.; Nicol, C. G.; Morecroft, I.; Channon, K. M.; Danilov, S. M.; Reynolds, P. N.; Baker, A. H.; Dominiczak, A. F. Targeting endothelial cells with adenovirus expressing nitric oxide synthase prevents elevation of blood pressure in stroke-prone spontaneously hypertensive rats. Mol. Ther. 2005, 12, 321-327.
27. Reynolds, A. M.; Xia, M.; Holmes, M. D.; Hodge, S. J.; Danilov, S.; Curiel, D. T.; Morrell, N. W.; Reynolds, P. N. Bone morphogenetic protein type 2 receptor (BMPR2) gene therapy attenuates hypoxic pulmonary hypertension. Am. J. Physiol. (Lung Physiol.) 2007, 292, L1182-L1192.
28. Danilov, S. M. Faerman, A. I., Printseva, O. Y., Martynov, A. V., Sakharov, I. Y., and Trakht, I. N. Immunohistochemical study of angiotensin-converting enzyme in human tissues using monoclonal antibodies. Histochemistry 1987, 87, 487-490.
29. Falkenhahn, M.; Franke, F.; Bohle, R.-M.; Zhu, Y.-C.; Strauss.; H. M.; Bachmann, S.; Danilov, S.; Unger, T. Cellular distribution of angiotensin converting enzyme after myocardial infarction. Hypertension 1995, 25, 219-226.
30. Morrell, N. W.; Atochina, E. N.; Morris, K.; Danilov, S. M.; Stenmark, K. Angiotensin-converting enzyme expression is increased in small pulmonary arteries of rats with hypoxia-ihduced pulmonary hypertension. J Clin. Invest. 1995, 95, 1823-1833.
31. Metzger, R.; Bohle, R.-M.; Kerkman, L.; Eichner, G.; Alhenc-Gelas, F.; Danilov, S. M.; Franke, F. E. Distribution of angiotensin I-converting enzyme (CD 143) in the normal human kidney and in non-neoplastic kidney diseases. Kidney Int. 1999, 56, 1442-1454.
32. Metzger, R.; Bohle, R.-M.; Chumachenko, P.; Danilov, S. M.; Franke, F. E. CD 143 in the development of atherosclerosis. Atherosclerosis 2000, 150, 21-31.
33. Franke, F. E.; Fink, L.; Kerkman, L.; Steger, K.; Klonisch, T.; Metzger, R.; Alhenc-Gelas, F.; Burkhard, E.; Bergmann, M.; Danilov, S. M. Somatic isoform of angiotensin-converting enzyme in the pathology of testicular germ cell tumors. Human Pathol. 2000, 31, 1466-1476.
34. Pauls, K.; Metzger, R.; Steger, K.; Klonisch, T.; Danilov, S.; Franke, F. E. Isoforms of angiotensin I-converting enzyme in the development and differentiation of human testis and epididymis. Andrologia 2003, 35, 32-42.
35. Danilov, S. M.; Martynov, A.; Klibanov, A. L.; Slinkin, M. A.; Sakharov, I. Y.; Malov, A. G.; Sergienko, V. B.; Vedernikov, A. Y.; Muzykantov, V. R.; Torchilin, V. P. Radioimmunoimaging of lung vessels: an approach using 111-In-labeled monoclonal antibody to angiotensin-converting enzyme. J Nucl. Med. 1989, 30, 1688-1692.
36. Muzykantov, V. R.; Danilov, S. M. Targeting of radiolabelled monoclonal antibody against angiotensin-converting enzyme to the pulmonary vasculature. In: Handbook of Targeting Delivery of Imaging Agents.; Torchilin, V. P., Ed.; CRC: Boca Raton, FL, 1995.; pp 465-486.
37. Bordier, C. Phase separation of integral membrane proteins in Triton X-114 solution. J Biol. Chem. 1981, 256, 1604-1607.
38. Gordon, K.; Redelinghuys, P.; Schwager, S. L.; Ehlers, M. R.; Papageorgiou, A. C.; Natesh, R.; Acharya, K. R.; Sturrock, E. D. Deglycosylation, processing and crystallization of human testis angiotensin-converting enzyme. Biochem. J. 2003, 371 (Pt 2), 437-442.
39. Woodman, Z. L.; Schwager, S. L.; Redelinghuys, P.; Chubb, A. J.; van der Merwe, E. L.; Ehlers, M. R.; Sturrock, E. D. Homologous substitution of ACE C domain regions with N domain sequences: effect on processing, shedding, and catalytic properties. Biol. Chem. 2006, 387, 1043-1051.
40. Towler, P.; Staker, B.; Prasad, S. G.; Menon, S.; Tang, J.; Parsons, T.; Ryan, D.; Fisher, M.; Williams, D.; Dales, N. A.; Patane, M. A.; Pantoliano, M. W. ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis. J Biol. Chem. 2004, 279, 17996-18006.
41. Thompson, J. D.; Higgins, D. G.; Gibson, T. J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, positions, specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994, 22, 4673-4680.
42. Naperova, I. A.; Balyasnikova, I.V.; Petrov, M. N.; Vakhitova, A. V.; Evdokimov, V. V.; Danilov, S. M.; Kost, O. A. Characterization of the binding of monoclonal antibodies to the C domain of human angiotensin I-converting enzyme. Bioorg. Chem. (Moscow) 2008, 34, 358-364.
43. Dufour, C.; Casane, D.; Denton, D.; Wickings, J.; Corvol, P.; Jeanmaitre, X. Human-chimpanzee DNA sequence variation in the four major genes of the renin-angiotensin sytem. Genomics 2000, 69, 14-26.
44. Ehlers, M. R. W.; Chen, Y.-N.; Riordan, J. F. Spontaneous solubilization of membrane-bound human testis angiotensin-converting enzyme expressed in Chinese hamster ovary cells. Proc. Natl. Acad. Sci. U.SA. 1991, 88, 1009-1013.
45. Yu, X. C.; Sturrock, E. D.; Wu, Z.; Biemann, K.; Ehlers, M. R. W.; Riordan, I. F. Identification of N-linked glycosylation sites in human testis angiotensin-converting enzyme and expression of an active deglycosylated form. J Biol. Chem. 1997, 272, 3511-3519.
46. Balyasnikova, I. V.; Gavriljuk, V. D.; McDonald, T. D.; Berkowitz, R.; Miletich.; D.J.; Danilov, S. M. Antibody-mediated lung endothelium targeting. In vitro model using a cell line expressing angiotensin-converting enzyme. Tumor Targeting 1999, 4, 70-83.
47. Schwager, S. L.; Chubb, A. J.; Scholle, R. R.; Brandt, W. F.; Mentele, R.; Riordan, J. F.; Sturrock, E. D.; Ehlers, M. R. Modulation of juxtamembrane cleavage ("shedding") of angiotensin-converting enzyme by stalk glycosylation: evidence for an alternative shedding protease. Biochemistry 1999, 38, 10388-10397.
48. Pang, S.; Chubb, A. J.; Schwager, S. L. U.; Ehlers, M. R. W.; Sturrock, E. D.; Hooper, N. M. Roles of the juxtamembrane and extracellular domains of angiotensin-converting enzyme in ectodomain shedding. Biochem. J. 2001, 358, 185-192.
49. Chubb, A. J.; Schwager, S. L.; Woodman, Z. L.; Ehlers, M.; Sturrock, E. D. Denning the boundaries of the testis angiotensin-converting enzyme ectodomain. Biochem. Biophys. Res. Commun. 2002, 297, 1225-1230.
50. Wei, L.; Alhenc-Gelas, F.; Corvol, P.; Clauser, E. The two homologous domains of human angiotensin I-converting enzyme are both catalytically active. J Biol. Chem. 1991, 266, 9002-9008.
51. Ripka, J. E.; Ryan, J. W.; Valido, F. A.; Chung, A. Y.; Peterson, C. M.; Urry, R. L. N-glycosylation of forms of angiotensin converting enzyme from four mammalian species. Biochem. Biophys. Res. Commun. 1993, 196, 503-508.
52. Weigel, P. H. Galactosyl and N-acetylgalactosaminyl homeostasis: a function for mammalian asialoglycoprotein receptors. Bioessays 1994, 16, 519-524.
53. Williams, T. A.; Danilov, S. M.; Alhenc-Gelas, F.; Soubrier, F. A study of chimeras constructed with the two domains of angiotensin I-converting enzyme. Biochem. Pharmacol. 1996, 51, 11-14.
54. Jaspard, E.; Alhenc-Gelas, F. Catalytic properties of the two active sites of angiotensin I-converting enzyme on the cell surface. Biochem. Biophys. Res. Commun. 1995, 211, 528-534.
55. Krege, J. H.; John, S. W.; Langenbach, L. L.; Hodgin, J. B.; Hagaman, J. R.; Bachman, E. S.; Jennette, J. C.; O'Brien, D. A.; Smithies, O. Male-female differences in fertility and blood pressure in ACE-deficient mice. Nature 1995, 375, 146-148.
56. Hagaman, J. R.; Moyer, J. S.; Bachman, E. S.; Sibony, M.; Magyar, P. L.; Welch, J. E.; Smithies, O.; Krege, J. H.; O'Brien, D. A. Angiotensin-converting enzyme and male fertility. Proc. Natl. Acad. Sci. USA 1998, 95, 2552-2557.
57. Kessler, S. P.; Rowe, T. M.; Gomos, J. B.; Kessler, P. M.; Sen, G. C. Physiological nonequivalence of the two isoforms of angiotensin-converting enzyme. J Biol. Chem. 2000, 275, 26259-26264.
58. Fuchs, S.; Frenzel, K.; Hubert, C.; Lyng, R.; Muller, L.; Michaud, A.; Xiao, H. D.; Adams, J. W.; Capecchi, M. R.; Corvol.; P.; Shur, B. D.; Bernstein, K. E. Male fertility is dependent on dipeptidase activity of testis ACE. Nat. Med. 2006, 11, 1140-1142.
59. Deguchi, E.; Tani, T.; Watanabe, H.; Yamada, S.; Kondoh, G. Dipeptidase-inactivated tACE action in vivo: Selective inhibition of sperm-zona pellucida binding in the mouse. Biol. Reprod. 2007, 77, 794-802.
60. Balyasnikova, I. V.; Sun, Z.-L.; Metzger, R.; Taylor, P. R.; Vicini, E.; Muciaccia, B.; Visintine, D. J.; Berestetskaya, Y. V.; McDonald, T. D.; Danilov, S. M. Monoclonal antibodies to native mouse angiotensin-converting enzyme (CD143): ACE expression, quantification, lung endothelial cell targeting and gene delivery. Tissue Antigens 2006, 67, 10-29.
61. Jokubaitis, V. J.; Sinka, L.; Driessen, R.; Whitty, G.; Haylock, D. N.; Bertoncello, I.; Smith, I.; Peault, B.; Tavian, M.; Simmons, P. J. Angiotensin-converting enzyme (CD 143) marks hematopoietic stem cells in human embryonic, fetal and adult hematopoietic tissues. Blood 2008, 111, 4055-4063.
62. Natesh, R.; Schwager, S. L.; Sturrock, E. D.; Acharya, K. R. Crystal structure of the human angiotensin-converting enzyme-lisinopril complex. Nature 2003, 421, 551-554.
63. Watermeyer, J. M.; Sewell, B. T.; Schwager, S. L.; Natesh, R.; Corradi, H. R.; Acharya, K. R.; Sturrock, E. D. Structure of testis ACE glycosylation mutants and evidence for conserved domain movement. Biochemistry 2006, 45, 12654-63.
64. Danilov, S. M.; Deinum, J.; Balyasnikova, I. V.; Sun, Z. L.; Kramers, C.; Hollak, C. E.; Albrecht, R. F. Detection of mutated angiotensin I-converting enzyme by serum/plasma analysis using a pair of monoclonal antibodies. Clin. Chem. 2005, 51, 1040-1043.
65. Semmler, A.; Stein, R. W.; Caplan, L.; Danilov, S. M.; Klockgether, T.; Linnebank, M. Hereditary hyper-ACE-emia due to the Pro 1199Leu mutation of somatic ACE as a potential pitfall in diagnosis: a first family out of Europe. Clin. Chem. Lab. Med. 2006, 44, 1088-1089.
66. Hunziker, W.; Spiess, M.; Semenza, G.; Lodish, H. F. The sucrase-isomaltase complex: primary structure, membrane-orientation, and evolution of a stalked, intrinsic brush border protein. Cell 1986, 46, 227-234.
67. Mantei, N.; Villa, M.; Enzler, T.; Wacker, H.; Boll, W.; James, P.; Hunziker, W.; Semenza, G. Complete primary structure of human and rabbit lactase-phlorizin hydrolase: implications for biosynthesis, membrane anchroring and evolution of the enzyme. EMBO J. 1988, 7, 2705-2713.
68. Ellgaard, L.; Ruddock, L. W. The human protein disulphide isomerase family: substrate interactions and functional properties. EMBO Rep. 2005, 6, 28-32.
69. Jaggi, R.; van Heeswijk, W. C.; Westerhoff, H. V.; Ollis, D. L.; Vasudevan, S. G. The two opposing activities of adenylyl transferase reside in distinct homologous domains, with intramolecular signal transduction. EMBO J. 1997, 16, 55362-55371.
70. Rousseau, A.; Michaud, A.; Chauvet, M. T.; Lenfant, M.; Corvol, P. The hemoregulatory peptide N-acetyl-Ser-Asp-Lys-Pro is a natural and specific substrate of the N-terminal active site of human angiotensin-converting enzyme. J Biol. Chem. 1995, 270, 3656-3661.
71. Dive, V.; Cotton, J.; Yiotakis, A.; Michaud, A.; Vassiliou, S.; Jiracek, J.; Vazeux, G.; Chauvet, M. T.; Cuniasse, P.; Corvol, P. RXP 407, a phosphinic peptide, is a potent inhibitor of angiotensin I converting enzyme able to differentiate between its two active sites. Proc. Natl. Acad. Sci. U.SA. 1999, 96, 4330-4335.
72. Georgiadis, D.; Beau, F.; Czarny, B.; Cotton, J.; Yiotakis, A.; Dive, V. Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitors. Circ. Res. 2003, 93, 148-154.
73. Wei, L.; Clauser, E.; Alhenc-Gelas, F.; Corvol, P. The two homologous domains of human angiotensin I-converting enzyme interact differenty with competitive inhibitors. J Biol. Chem. 1992, 267, 13398-13405.
74. Deddish, P. A.; Wang, L.-X.; Jackman, H. L.; Michel, B.; Wang, J.; Skidgel, R. A.; Erdos, E. G. Single-domain angiotensin I converting enzyme (kininase II): characterization and properties. J Pharmacol. Exp. Ther. 1996, 279, 1582-1589.
75. Voronov, S.; Zueva, N.; Orlov, V.; Arutyunyan, A.; Kost, O. Temperature-induced selective death of the C-domain within angiotensin- converting enzyme molecule. FEBS Lett. 2002, 522, 77-82.
76. Binevski, P. V.; Sizova, E. A.; Pozdnev, V. F.; Kost, O. A. Evidence for the negative cooperativity of the two active sites within bovine somatic angiotensin-converting enzyme. FEBS Lett. 2003, 550, 84-88.
77. Skirgello, O. E.; Binevski, P. V.; Pozdnev, V. F.; Kost, O. A. Kinetic probes for inter-domain co-operation in human somatic angiotensin-converting enzyme. Biochem. J. 2005, 391, 641-647.
78. Baudin, B.; Timmins, P. A.; Drouet, L.; Bauman, F. C. Molecular weight and shape of angiotensin-converting enzyme. A neutron scattering study. Biochem. Biophys. Res. Commun. 1988, 154,1144-1150.
79. Grinshtein, S. V.; Nikolskaya, I.I.; Klyachko, N. L.; Levashov, A. V.; Kost, O. A. Structural organization of membrane and soluble forms of somatic angiotensin-converting enzyme. Biochemistry (Moscow) 1999, 64, 571-580.
80. Kost, O. A.; Balyasnikova, I. V.; Chemodanova, E. E.; Nikolskaya, I.I.; Albrecht, R. F., II.; Danilov, S. M. Epitope-dependent blocking of the angiotensin-converting enzyme dimerization by monoclonal antibodies to N-terminal domain of ACE: Possible Link of ACE dimerization and shedding from the cell surface. Biochemistry 2003, 42, 6965-6976.
81. Nesterovitch, A.; Hogarth, K.; Berestetskaya, Y.; Albrecht, R. F., II.; Solway, J.; Danilov, S. M. A novel point mutation of angiotensin I-converting enzyme (Trpll97Stop) is associated with a dramatic increase in serum ACE in a patient with asthma. Am. J. Resp. Crit. Care Med. 2007, 175, A462.